Clinicopathological Analysis of Allogeneic Hematopoietic Stem Cell Transplantation-related Membranous Glomerulonephritis

Summary Allogeneic hematopoietic stem cell transplantation (HSCT)-related membranous glomerulonephritis (MGN) is poorly understood. A total of 830 patients who underwent HSCT at Toranomon Hospital from 2000 to 2012 were evaluated retrospectively, including 621 patients receiving umbilical cord blood...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human pathology 2016-04, Vol.50, p.187-194
Hauptverfasser: Hiramatsu, Rikako, MD, Ubara, Yoshifumi, MD, PhD, Sawa, Naoki, MD, Hasegawa, Eiko, MD, Kawada, Masahiro, MD, Imafuku, Aya, MD, Sumida, Keiichi, MD, Mise, Koki, MD, Yamanouchi, Masayuki, MD, Ueno, Toshiharu, MD, Sekine, Akinari, MD, Hayami, Noriko, MD, Suwabe, Tatsuya, MD, Hoshino, Junichi, MD, Takaichi, Kenmei, MD, Ohashi, Kenichi, MD, Fujii, Takeshi, Wake, Atsushi, Taniguchi, Shuichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 194
container_issue
container_start_page 187
container_title Human pathology
container_volume 50
creator Hiramatsu, Rikako, MD
Ubara, Yoshifumi, MD, PhD
Sawa, Naoki, MD
Hasegawa, Eiko, MD
Kawada, Masahiro, MD
Imafuku, Aya, MD
Sumida, Keiichi, MD
Mise, Koki, MD
Yamanouchi, Masayuki, MD
Ueno, Toshiharu, MD
Sekine, Akinari, MD
Hayami, Noriko, MD
Suwabe, Tatsuya, MD
Hoshino, Junichi, MD
Takaichi, Kenmei, MD
Ohashi, Kenichi, MD
Fujii, Takeshi
Wake, Atsushi
Taniguchi, Shuichi
description Summary Allogeneic hematopoietic stem cell transplantation (HSCT)-related membranous glomerulonephritis (MGN) is poorly understood. A total of 830 patients who underwent HSCT at Toranomon Hospital from 2000 to 2012 were evaluated retrospectively, including 621 patients receiving umbilical cord blood transplantation (UCBT) and 208 patients receiving unrelated bone marrow transplantation (BMT). MGN was diagnosed in 5 patients after UCBT (vs. none after BMT), and occurred concomitantly with chronic graft-versus-host-disease after cessation of immunosuppression. LM did not show any definite spikes or bubbling of the glomerular basement membrane (GBM) in all 5 patients. In 1 patient (case 5), endocapillary proliferative lesions with fibrin-like deposits were noted in addition to MGN findings. IF demonstrated granular deposits of IgG (IgG1 and IgG4) along the GBM with negativity for C3, C4, and C1q in 4 patients (cases 1-4), while case 5 showed positivity for IgG (IgG1, IgG2, IgG3, and IgG4) as well as for C3, C4, and C1q. EM revealed electron-dense deposits (EDD) in the subepithelial space of the GBM in cases 1-4. In case 5, EDD were present in the mesangium and the subendothelial space of the GBM, as well as in the subepithelial space. After treatment with immunosuppressants (prednisolone and/or cyclosporin) or angiotensin-converting enzyme inhibitors, complete remission with disappearance of proteinuria was achieved 12.2 months in all 5 patients, but nephrotic range proteinuria relapsed in two patients during follow up. Serum anti-PLA2R autoantibody was negative in three patients. HSCT-related MGN only occurred after umbilical cord blood transplantation (UCBT). We believe that there were two morphologic patterns; early MGN and membranoproliferative pattern glomerulonephritis.
doi_str_mv 10.1016/j.humpath.2015.12.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1775170778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0046817715004967</els_id><sourcerecordid>4319290321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c561t-a47ed16c957b66a4bf03ff94e59231be0783d178de82977fb7e0973e6527b2af3</originalsourceid><addsrcrecordid>eNqFUk1v1DAUtBCILlt-AigSFy4JthPbyQW0WvUDqaiHlrPlOC-sFycOtoO6_75OdwGpF07-mpn3PPMQekdwQTDhn_bFbh4mFXcFxYQVhBYYsxdoRVhJ87ps6Eu0wrjieU2EOENvQthjTAir2Gt0RnnTiIqxFXrYWjMa7RYlZ90Po5XNNqOyh2BC5vpsY9MtjGB0dg2Dim5yBmI63UUYsi1Ym917NYbJqjGqaNyYe7AqQpd9g6FNT24O2ZV1A_jZuhGmnTfRhHP0qlc2wNvTukbfLy_ut9f5ze3V1-3mJteMk5irSkBHuG6YaDlXVdvjsu-bClhDS9ICFnXZEVF3UNNGiL4VgBtRAmdUtFT15Rp9POpO3v2aIUQ5mKBT22qE1JlM7jAisEg6a_ThGXTvZp-8SKhaVHVFKGYJxY4o7V0IHno5eTMof5AEyyUauZenaOQSjSRU4ife-5P63A7Q_WX9ySIBvhwBkOz4bcDLoA2MGjrjQUfZOfPfEp-fKeindJX9CQcI_34jQyLIu2U-lvEgLO0aLspHWzG5dQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1874841205</pqid></control><display><type>article</type><title>Clinicopathological Analysis of Allogeneic Hematopoietic Stem Cell Transplantation-related Membranous Glomerulonephritis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hiramatsu, Rikako, MD ; Ubara, Yoshifumi, MD, PhD ; Sawa, Naoki, MD ; Hasegawa, Eiko, MD ; Kawada, Masahiro, MD ; Imafuku, Aya, MD ; Sumida, Keiichi, MD ; Mise, Koki, MD ; Yamanouchi, Masayuki, MD ; Ueno, Toshiharu, MD ; Sekine, Akinari, MD ; Hayami, Noriko, MD ; Suwabe, Tatsuya, MD ; Hoshino, Junichi, MD ; Takaichi, Kenmei, MD ; Ohashi, Kenichi, MD ; Fujii, Takeshi ; Wake, Atsushi ; Taniguchi, Shuichi</creator><creatorcontrib>Hiramatsu, Rikako, MD ; Ubara, Yoshifumi, MD, PhD ; Sawa, Naoki, MD ; Hasegawa, Eiko, MD ; Kawada, Masahiro, MD ; Imafuku, Aya, MD ; Sumida, Keiichi, MD ; Mise, Koki, MD ; Yamanouchi, Masayuki, MD ; Ueno, Toshiharu, MD ; Sekine, Akinari, MD ; Hayami, Noriko, MD ; Suwabe, Tatsuya, MD ; Hoshino, Junichi, MD ; Takaichi, Kenmei, MD ; Ohashi, Kenichi, MD ; Fujii, Takeshi ; Wake, Atsushi ; Taniguchi, Shuichi</creatorcontrib><description>Summary Allogeneic hematopoietic stem cell transplantation (HSCT)-related membranous glomerulonephritis (MGN) is poorly understood. A total of 830 patients who underwent HSCT at Toranomon Hospital from 2000 to 2012 were evaluated retrospectively, including 621 patients receiving umbilical cord blood transplantation (UCBT) and 208 patients receiving unrelated bone marrow transplantation (BMT). MGN was diagnosed in 5 patients after UCBT (vs. none after BMT), and occurred concomitantly with chronic graft-versus-host-disease after cessation of immunosuppression. LM did not show any definite spikes or bubbling of the glomerular basement membrane (GBM) in all 5 patients. In 1 patient (case 5), endocapillary proliferative lesions with fibrin-like deposits were noted in addition to MGN findings. IF demonstrated granular deposits of IgG (IgG1 and IgG4) along the GBM with negativity for C3, C4, and C1q in 4 patients (cases 1-4), while case 5 showed positivity for IgG (IgG1, IgG2, IgG3, and IgG4) as well as for C3, C4, and C1q. EM revealed electron-dense deposits (EDD) in the subepithelial space of the GBM in cases 1-4. In case 5, EDD were present in the mesangium and the subendothelial space of the GBM, as well as in the subepithelial space. After treatment with immunosuppressants (prednisolone and/or cyclosporin) or angiotensin-converting enzyme inhibitors, complete remission with disappearance of proteinuria was achieved 12.2 months in all 5 patients, but nephrotic range proteinuria relapsed in two patients during follow up. Serum anti-PLA2R autoantibody was negative in three patients. HSCT-related MGN only occurred after umbilical cord blood transplantation (UCBT). We believe that there were two morphologic patterns; early MGN and membranoproliferative pattern glomerulonephritis.</description><identifier>ISSN: 0046-8177</identifier><identifier>EISSN: 1532-8392</identifier><identifier>DOI: 10.1016/j.humpath.2015.12.005</identifier><identifier>PMID: 26997455</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Allogeneic hematopoietic cell transplantation ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Anti-PLA2R autoantibody ; Biomarkers - analysis ; Biopsy ; Blood ; Chronic graft-versus-host disease ; Disease ; Enzymes ; Female ; Fluorescent Antibody Technique ; Gangrene ; Glomerulonephritis, Membranoproliferative - diagnosis ; Glomerulonephritis, Membranoproliferative - drug therapy ; Glomerulonephritis, Membranoproliferative - etiology ; Glomerulonephritis, Membranous - diagnosis ; Glomerulonephritis, Membranous - drug therapy ; Glomerulonephritis, Membranous - etiology ; Hematopoietic Stem Cell Transplantation - adverse effects ; Hepatitis ; Histology ; Humans ; Immunosuppressive Agents - therapeutic use ; Japan ; Kidney - chemistry ; Kidney - drug effects ; Kidney - immunology ; Kidney - ultrastructure ; Laboratories ; Leukemia ; Lymphoma ; Male ; Membranoproliferative pattern glomerulonephritis ; Membranous glomerulonephritis ; Microscopy ; Microscopy, Electron ; Middle Aged ; Pathology ; Patients ; Proteins ; Proteinuria - etiology ; Remission Induction ; Retrospective Studies ; Statistical analysis ; Stem cells ; Time Factors ; Transplantation, Homologous ; Treatment Outcome ; Umbilical cord blood transplantation ; Unrelated bone marrow transplantation ; Urine</subject><ispartof>Human pathology, 2016-04, Vol.50, p.187-194</ispartof><rights>2015 The Authors</rights><rights>Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Apr 01, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c561t-a47ed16c957b66a4bf03ff94e59231be0783d178de82977fb7e0973e6527b2af3</citedby><cites>FETCH-LOGICAL-c561t-a47ed16c957b66a4bf03ff94e59231be0783d178de82977fb7e0973e6527b2af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0046817715004967$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26997455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hiramatsu, Rikako, MD</creatorcontrib><creatorcontrib>Ubara, Yoshifumi, MD, PhD</creatorcontrib><creatorcontrib>Sawa, Naoki, MD</creatorcontrib><creatorcontrib>Hasegawa, Eiko, MD</creatorcontrib><creatorcontrib>Kawada, Masahiro, MD</creatorcontrib><creatorcontrib>Imafuku, Aya, MD</creatorcontrib><creatorcontrib>Sumida, Keiichi, MD</creatorcontrib><creatorcontrib>Mise, Koki, MD</creatorcontrib><creatorcontrib>Yamanouchi, Masayuki, MD</creatorcontrib><creatorcontrib>Ueno, Toshiharu, MD</creatorcontrib><creatorcontrib>Sekine, Akinari, MD</creatorcontrib><creatorcontrib>Hayami, Noriko, MD</creatorcontrib><creatorcontrib>Suwabe, Tatsuya, MD</creatorcontrib><creatorcontrib>Hoshino, Junichi, MD</creatorcontrib><creatorcontrib>Takaichi, Kenmei, MD</creatorcontrib><creatorcontrib>Ohashi, Kenichi, MD</creatorcontrib><creatorcontrib>Fujii, Takeshi</creatorcontrib><creatorcontrib>Wake, Atsushi</creatorcontrib><creatorcontrib>Taniguchi, Shuichi</creatorcontrib><title>Clinicopathological Analysis of Allogeneic Hematopoietic Stem Cell Transplantation-related Membranous Glomerulonephritis</title><title>Human pathology</title><addtitle>Hum Pathol</addtitle><description>Summary Allogeneic hematopoietic stem cell transplantation (HSCT)-related membranous glomerulonephritis (MGN) is poorly understood. A total of 830 patients who underwent HSCT at Toranomon Hospital from 2000 to 2012 were evaluated retrospectively, including 621 patients receiving umbilical cord blood transplantation (UCBT) and 208 patients receiving unrelated bone marrow transplantation (BMT). MGN was diagnosed in 5 patients after UCBT (vs. none after BMT), and occurred concomitantly with chronic graft-versus-host-disease after cessation of immunosuppression. LM did not show any definite spikes or bubbling of the glomerular basement membrane (GBM) in all 5 patients. In 1 patient (case 5), endocapillary proliferative lesions with fibrin-like deposits were noted in addition to MGN findings. IF demonstrated granular deposits of IgG (IgG1 and IgG4) along the GBM with negativity for C3, C4, and C1q in 4 patients (cases 1-4), while case 5 showed positivity for IgG (IgG1, IgG2, IgG3, and IgG4) as well as for C3, C4, and C1q. EM revealed electron-dense deposits (EDD) in the subepithelial space of the GBM in cases 1-4. In case 5, EDD were present in the mesangium and the subendothelial space of the GBM, as well as in the subepithelial space. After treatment with immunosuppressants (prednisolone and/or cyclosporin) or angiotensin-converting enzyme inhibitors, complete remission with disappearance of proteinuria was achieved 12.2 months in all 5 patients, but nephrotic range proteinuria relapsed in two patients during follow up. Serum anti-PLA2R autoantibody was negative in three patients. HSCT-related MGN only occurred after umbilical cord blood transplantation (UCBT). We believe that there were two morphologic patterns; early MGN and membranoproliferative pattern glomerulonephritis.</description><subject>Adult</subject><subject>Allogeneic hematopoietic cell transplantation</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Anti-PLA2R autoantibody</subject><subject>Biomarkers - analysis</subject><subject>Biopsy</subject><subject>Blood</subject><subject>Chronic graft-versus-host disease</subject><subject>Disease</subject><subject>Enzymes</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>Gangrene</subject><subject>Glomerulonephritis, Membranoproliferative - diagnosis</subject><subject>Glomerulonephritis, Membranoproliferative - drug therapy</subject><subject>Glomerulonephritis, Membranoproliferative - etiology</subject><subject>Glomerulonephritis, Membranous - diagnosis</subject><subject>Glomerulonephritis, Membranous - drug therapy</subject><subject>Glomerulonephritis, Membranous - etiology</subject><subject>Hematopoietic Stem Cell Transplantation - adverse effects</subject><subject>Hepatitis</subject><subject>Histology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Japan</subject><subject>Kidney - chemistry</subject><subject>Kidney - drug effects</subject><subject>Kidney - immunology</subject><subject>Kidney - ultrastructure</subject><subject>Laboratories</subject><subject>Leukemia</subject><subject>Lymphoma</subject><subject>Male</subject><subject>Membranoproliferative pattern glomerulonephritis</subject><subject>Membranous glomerulonephritis</subject><subject>Microscopy</subject><subject>Microscopy, Electron</subject><subject>Middle Aged</subject><subject>Pathology</subject><subject>Patients</subject><subject>Proteins</subject><subject>Proteinuria - etiology</subject><subject>Remission Induction</subject><subject>Retrospective Studies</subject><subject>Statistical analysis</subject><subject>Stem cells</subject><subject>Time Factors</subject><subject>Transplantation, Homologous</subject><subject>Treatment Outcome</subject><subject>Umbilical cord blood transplantation</subject><subject>Unrelated bone marrow transplantation</subject><subject>Urine</subject><issn>0046-8177</issn><issn>1532-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk1v1DAUtBCILlt-AigSFy4JthPbyQW0WvUDqaiHlrPlOC-sFycOtoO6_75OdwGpF07-mpn3PPMQekdwQTDhn_bFbh4mFXcFxYQVhBYYsxdoRVhJ87ps6Eu0wrjieU2EOENvQthjTAir2Gt0RnnTiIqxFXrYWjMa7RYlZ90Po5XNNqOyh2BC5vpsY9MtjGB0dg2Dim5yBmI63UUYsi1Ym917NYbJqjGqaNyYe7AqQpd9g6FNT24O2ZV1A_jZuhGmnTfRhHP0qlc2wNvTukbfLy_ut9f5ze3V1-3mJteMk5irSkBHuG6YaDlXVdvjsu-bClhDS9ICFnXZEVF3UNNGiL4VgBtRAmdUtFT15Rp9POpO3v2aIUQ5mKBT22qE1JlM7jAisEg6a_ThGXTvZp-8SKhaVHVFKGYJxY4o7V0IHno5eTMof5AEyyUauZenaOQSjSRU4ife-5P63A7Q_WX9ySIBvhwBkOz4bcDLoA2MGjrjQUfZOfPfEp-fKeindJX9CQcI_34jQyLIu2U-lvEgLO0aLspHWzG5dQ</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Hiramatsu, Rikako, MD</creator><creator>Ubara, Yoshifumi, MD, PhD</creator><creator>Sawa, Naoki, MD</creator><creator>Hasegawa, Eiko, MD</creator><creator>Kawada, Masahiro, MD</creator><creator>Imafuku, Aya, MD</creator><creator>Sumida, Keiichi, MD</creator><creator>Mise, Koki, MD</creator><creator>Yamanouchi, Masayuki, MD</creator><creator>Ueno, Toshiharu, MD</creator><creator>Sekine, Akinari, MD</creator><creator>Hayami, Noriko, MD</creator><creator>Suwabe, Tatsuya, MD</creator><creator>Hoshino, Junichi, MD</creator><creator>Takaichi, Kenmei, MD</creator><creator>Ohashi, Kenichi, MD</creator><creator>Fujii, Takeshi</creator><creator>Wake, Atsushi</creator><creator>Taniguchi, Shuichi</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20160401</creationdate><title>Clinicopathological Analysis of Allogeneic Hematopoietic Stem Cell Transplantation-related Membranous Glomerulonephritis</title><author>Hiramatsu, Rikako, MD ; Ubara, Yoshifumi, MD, PhD ; Sawa, Naoki, MD ; Hasegawa, Eiko, MD ; Kawada, Masahiro, MD ; Imafuku, Aya, MD ; Sumida, Keiichi, MD ; Mise, Koki, MD ; Yamanouchi, Masayuki, MD ; Ueno, Toshiharu, MD ; Sekine, Akinari, MD ; Hayami, Noriko, MD ; Suwabe, Tatsuya, MD ; Hoshino, Junichi, MD ; Takaichi, Kenmei, MD ; Ohashi, Kenichi, MD ; Fujii, Takeshi ; Wake, Atsushi ; Taniguchi, Shuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c561t-a47ed16c957b66a4bf03ff94e59231be0783d178de82977fb7e0973e6527b2af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Allogeneic hematopoietic cell transplantation</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Anti-PLA2R autoantibody</topic><topic>Biomarkers - analysis</topic><topic>Biopsy</topic><topic>Blood</topic><topic>Chronic graft-versus-host disease</topic><topic>Disease</topic><topic>Enzymes</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>Gangrene</topic><topic>Glomerulonephritis, Membranoproliferative - diagnosis</topic><topic>Glomerulonephritis, Membranoproliferative - drug therapy</topic><topic>Glomerulonephritis, Membranoproliferative - etiology</topic><topic>Glomerulonephritis, Membranous - diagnosis</topic><topic>Glomerulonephritis, Membranous - drug therapy</topic><topic>Glomerulonephritis, Membranous - etiology</topic><topic>Hematopoietic Stem Cell Transplantation - adverse effects</topic><topic>Hepatitis</topic><topic>Histology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Japan</topic><topic>Kidney - chemistry</topic><topic>Kidney - drug effects</topic><topic>Kidney - immunology</topic><topic>Kidney - ultrastructure</topic><topic>Laboratories</topic><topic>Leukemia</topic><topic>Lymphoma</topic><topic>Male</topic><topic>Membranoproliferative pattern glomerulonephritis</topic><topic>Membranous glomerulonephritis</topic><topic>Microscopy</topic><topic>Microscopy, Electron</topic><topic>Middle Aged</topic><topic>Pathology</topic><topic>Patients</topic><topic>Proteins</topic><topic>Proteinuria - etiology</topic><topic>Remission Induction</topic><topic>Retrospective Studies</topic><topic>Statistical analysis</topic><topic>Stem cells</topic><topic>Time Factors</topic><topic>Transplantation, Homologous</topic><topic>Treatment Outcome</topic><topic>Umbilical cord blood transplantation</topic><topic>Unrelated bone marrow transplantation</topic><topic>Urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hiramatsu, Rikako, MD</creatorcontrib><creatorcontrib>Ubara, Yoshifumi, MD, PhD</creatorcontrib><creatorcontrib>Sawa, Naoki, MD</creatorcontrib><creatorcontrib>Hasegawa, Eiko, MD</creatorcontrib><creatorcontrib>Kawada, Masahiro, MD</creatorcontrib><creatorcontrib>Imafuku, Aya, MD</creatorcontrib><creatorcontrib>Sumida, Keiichi, MD</creatorcontrib><creatorcontrib>Mise, Koki, MD</creatorcontrib><creatorcontrib>Yamanouchi, Masayuki, MD</creatorcontrib><creatorcontrib>Ueno, Toshiharu, MD</creatorcontrib><creatorcontrib>Sekine, Akinari, MD</creatorcontrib><creatorcontrib>Hayami, Noriko, MD</creatorcontrib><creatorcontrib>Suwabe, Tatsuya, MD</creatorcontrib><creatorcontrib>Hoshino, Junichi, MD</creatorcontrib><creatorcontrib>Takaichi, Kenmei, MD</creatorcontrib><creatorcontrib>Ohashi, Kenichi, MD</creatorcontrib><creatorcontrib>Fujii, Takeshi</creatorcontrib><creatorcontrib>Wake, Atsushi</creatorcontrib><creatorcontrib>Taniguchi, Shuichi</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Human pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hiramatsu, Rikako, MD</au><au>Ubara, Yoshifumi, MD, PhD</au><au>Sawa, Naoki, MD</au><au>Hasegawa, Eiko, MD</au><au>Kawada, Masahiro, MD</au><au>Imafuku, Aya, MD</au><au>Sumida, Keiichi, MD</au><au>Mise, Koki, MD</au><au>Yamanouchi, Masayuki, MD</au><au>Ueno, Toshiharu, MD</au><au>Sekine, Akinari, MD</au><au>Hayami, Noriko, MD</au><au>Suwabe, Tatsuya, MD</au><au>Hoshino, Junichi, MD</au><au>Takaichi, Kenmei, MD</au><au>Ohashi, Kenichi, MD</au><au>Fujii, Takeshi</au><au>Wake, Atsushi</au><au>Taniguchi, Shuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathological Analysis of Allogeneic Hematopoietic Stem Cell Transplantation-related Membranous Glomerulonephritis</atitle><jtitle>Human pathology</jtitle><addtitle>Hum Pathol</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>50</volume><spage>187</spage><epage>194</epage><pages>187-194</pages><issn>0046-8177</issn><eissn>1532-8392</eissn><abstract>Summary Allogeneic hematopoietic stem cell transplantation (HSCT)-related membranous glomerulonephritis (MGN) is poorly understood. A total of 830 patients who underwent HSCT at Toranomon Hospital from 2000 to 2012 were evaluated retrospectively, including 621 patients receiving umbilical cord blood transplantation (UCBT) and 208 patients receiving unrelated bone marrow transplantation (BMT). MGN was diagnosed in 5 patients after UCBT (vs. none after BMT), and occurred concomitantly with chronic graft-versus-host-disease after cessation of immunosuppression. LM did not show any definite spikes or bubbling of the glomerular basement membrane (GBM) in all 5 patients. In 1 patient (case 5), endocapillary proliferative lesions with fibrin-like deposits were noted in addition to MGN findings. IF demonstrated granular deposits of IgG (IgG1 and IgG4) along the GBM with negativity for C3, C4, and C1q in 4 patients (cases 1-4), while case 5 showed positivity for IgG (IgG1, IgG2, IgG3, and IgG4) as well as for C3, C4, and C1q. EM revealed electron-dense deposits (EDD) in the subepithelial space of the GBM in cases 1-4. In case 5, EDD were present in the mesangium and the subendothelial space of the GBM, as well as in the subepithelial space. After treatment with immunosuppressants (prednisolone and/or cyclosporin) or angiotensin-converting enzyme inhibitors, complete remission with disappearance of proteinuria was achieved 12.2 months in all 5 patients, but nephrotic range proteinuria relapsed in two patients during follow up. Serum anti-PLA2R autoantibody was negative in three patients. HSCT-related MGN only occurred after umbilical cord blood transplantation (UCBT). We believe that there were two morphologic patterns; early MGN and membranoproliferative pattern glomerulonephritis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26997455</pmid><doi>10.1016/j.humpath.2015.12.005</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0046-8177
ispartof Human pathology, 2016-04, Vol.50, p.187-194
issn 0046-8177
1532-8392
language eng
recordid cdi_proquest_miscellaneous_1775170778
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Allogeneic hematopoietic cell transplantation
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Anti-PLA2R autoantibody
Biomarkers - analysis
Biopsy
Blood
Chronic graft-versus-host disease
Disease
Enzymes
Female
Fluorescent Antibody Technique
Gangrene
Glomerulonephritis, Membranoproliferative - diagnosis
Glomerulonephritis, Membranoproliferative - drug therapy
Glomerulonephritis, Membranoproliferative - etiology
Glomerulonephritis, Membranous - diagnosis
Glomerulonephritis, Membranous - drug therapy
Glomerulonephritis, Membranous - etiology
Hematopoietic Stem Cell Transplantation - adverse effects
Hepatitis
Histology
Humans
Immunosuppressive Agents - therapeutic use
Japan
Kidney - chemistry
Kidney - drug effects
Kidney - immunology
Kidney - ultrastructure
Laboratories
Leukemia
Lymphoma
Male
Membranoproliferative pattern glomerulonephritis
Membranous glomerulonephritis
Microscopy
Microscopy, Electron
Middle Aged
Pathology
Patients
Proteins
Proteinuria - etiology
Remission Induction
Retrospective Studies
Statistical analysis
Stem cells
Time Factors
Transplantation, Homologous
Treatment Outcome
Umbilical cord blood transplantation
Unrelated bone marrow transplantation
Urine
title Clinicopathological Analysis of Allogeneic Hematopoietic Stem Cell Transplantation-related Membranous Glomerulonephritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A15%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathological%20Analysis%20of%20Allogeneic%20Hematopoietic%20Stem%20Cell%20Transplantation-related%20Membranous%20Glomerulonephritis&rft.jtitle=Human%20pathology&rft.au=Hiramatsu,%20Rikako,%20MD&rft.date=2016-04-01&rft.volume=50&rft.spage=187&rft.epage=194&rft.pages=187-194&rft.issn=0046-8177&rft.eissn=1532-8392&rft_id=info:doi/10.1016/j.humpath.2015.12.005&rft_dat=%3Cproquest_cross%3E4319290321%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1874841205&rft_id=info:pmid/26997455&rft_els_id=S0046817715004967&rfr_iscdi=true